Differences in the peritumoural inflammatory skin infiltrate between squamous cell carcinomas in organ transplant recipients and immunocompetent patients

Acta Dermato-Venereologica

Volumn 90, Issue 4, 2010, Pages 379-385

  Krynitz, Britta ^a   Lundh Rozell, Barbro ^a   Lindelöf, Bemt ^b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Computer based image analysis; Cutaneous squamous cell carcinoma; Non melanoma skin cancer; Organ transplant recipient; Peritumoural inflammatory infiltrate

Indexed keywords

CD14 ANTIGEN; CD20 ANTIBODY; CD3 ANTIGEN; CD4 ANTIGEN; CD56 ANTIGEN; CD8 ANTIGEN; CHLORDANE; SYNDECAN 1; T6 ANTIGEN; FIXATIVE; FORMALDEHYDE; IMMUNOSUPPRESSIVE AGENT; LEUKOCYTE ANTIGEN; PARAFFIN;

ADULT; AGED; ARTICLE; CANCER RISK; CELL COUNT; CELL DENSITY; CELL TYPE; COMPUTER ANALYSIS; CONTROLLED STUDY; FEMALE; GRAFT RECIPIENT; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOCOMPROMISED PATIENT; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; MALE; MONOCYTE; MORPHOMETRICS; ORGAN TRANSPLANTATION; PERITUMORAL INFLAMMATORY SKIN INFILTRATION; PLASMA CELL; PRIORITY JOURNAL; SKIN INFILTRATE; SQUAMOUS CELL CARCINOMA; T LYMPHOCYTE; TUMOR BIOPSY; TUMOR LOCALIZATION; COMPARATIVE STUDY; DERMATITIS; IMAGE PROCESSING; IMMUNOCOMPETENCE; IMMUNOLOGY; KIDNEY TRANSPLANTATION; LEUKOCYTE COUNT; MIDDLE AGED; PATHOLOGY; SKIN; SKIN TUMOR; SWEDEN; TISSUE FIXATION; TUMOR ASSOCIATED LEUKOCYTE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANTIGENS, CD; CARCINOMA, SQUAMOUS CELL; DERMATITIS; FEMALE; FIXATIVES; FORMALDEHYDE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOCOMPETENCE; IMMUNOCOMPROMISED HOST; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; LEUKOCYTE COUNT; LYMPHOCYTES, TUMOR-INFILTRATING; MALE; MIDDLE AGED; MONOCYTES; PARAFFIN EMBEDDING; PLASMA CELLS; SKIN; SKIN NEOPLASMS; SWEDEN; T-LYMPHOCYTES; TISSUE FIXATION;

EID: 77954943910     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.2340/00015555-0876     Document Type: Article

References (32)

1. World Health Organization. How common is skin cancer? [cited 2010 Feb 1]. Available from: URL: http://www.who.int/uv/faq/skincancer/en/index1.html
2. National Board of Health and Welfare CfE. Cancer incidence in Sweden. [cited 2010 Feb 1]. Available from: URL: http://www.socialstyrelsen.se/ publikationer
3. Lindelöf B, Sigurgeirsson B, Gäbel H, Stern RS. Incidence of skin cancer in 5356 patients following organ transplantation. Br J Dermatol 2000; 143: 513-519.
4. Adami J, Gäbel H, Lindelöf B, Ekström K, Rydh B, Glimelius B, et al. Cancer risk following organ transplantation: a nationwide cohort study in Sweden. Br J Cancer 2003; 89: 1221-1227. (Pubitemid 37363407)
5. Berg D, Otley CC. Skin cancer in organ transplant recipients: epidemiology, pathogenesis, and management. J Am Acad Dermatol 2002; 47: 1-17; quiz 8-20.
6. Lindelöf B, Jarnvik J, Ternesten-Bratel A, Granath F, Hedblad MA. Mortality and clinicopathological features of cutaneous squamous cell carcinoma in organ transplant recipients: a study of the Swedish cohort. Acta Derm Venereol 2006; 86: 219-222. (Pubitemid 43875206)
7. Smith KJ, Hamza S, Skelton H. Histologic features in primary cutaneous squamous cell carcinomas in immunocompromised patients focusing on organ transplant patients. Dermatol Surg 2004; 30: 634-641. (Pubitemid 38525894)
8. Harwood CA, Proby CM, McGregor JM, Sheaff MT, Leigh IM, Cerio R. Clinicopathologic features of skin cancer in organ transplant recipients: a retrospective case-control series. J Am Acad Dermatol 2006; 54: 290-300. (Pubitemid 43144399)
9. Buell JF, Gross TG, Woodle ES. Malignancy after transplantation. Transplantation. 2005; 80: S254-264.
10. O'Donovan P, Perrett CM, Zhang X, Montaner B, Xu YZ, Harwood CA, et al. Azathioprine and UVA light generate mutagenic oxidative DNA damage. Science 2005; 309: 1871-1874. (Pubitemid 41325100)
11. Odenbro Å. Skin cancer in relation to tobacco use and organ transplantation [thesis]. Stockholm: Karolinska Institutet; 2009.
12. Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet 2001; 357: 539-545.
13. Mueller MM. Inflammation in epithelial skin tumours: old stories and new ideas. Eur J Cancer 2006; 42: 735-744.
14. Kundu JK, Surh YJ. Inflammation: gearing the journey to cancer. Mutat Res 2008; 659: 15-30.
15. Ostrand-Rosenberg S. Immune surveillance: a balance between protumor and antitumor immunity. Curr Opin Genet Dev 2008; 18: 11-18. (Pubitemid 351694442)
16. Smith KJ, Hamza S, Skelton H. Topical imidazoquinoline therapy of cutaneous squamous cell carcinoma polarizes lymphoid and monocyte/macrophage populations to a Th1 and M1 cytokine pattern. Clin Exp Dermatol 2004; 29: 505-512. (Pubitemid 39278198)
17. Clark RA, Huang SJ, Murphy GF, Mollet IG, Hijnen D, Muthukuru M, et al. Human squamous cell carcinomas evade the immune response by down-regulation of vascular E-selectin and recruitment of regulatory T cells. J Exp Med 2008; 205: 2221-2234.
18. LeBoit PE, Weedon D, Sarasin A. World Health Organization Classification of Tumours. Pathology and Genetics of Skin Tumours. Lyon: IARC Press, 2006: p. 30-32.
19. Duffy JP, Smith PJ, Crocker J, Matthews HR. Combined staining method for the demonstration of tissue eosinophils and mast cells. J Histotechnology 1993; 16: 143-144. (Pubitemid 23164522)
20. Mehrany K, Byrd DR, Roenigk RK, Weenig RH, Phillips PK, Nguyen TH, et al. Lymphocytic infiltrates and subclinical epithelial tumor extension in patients with chronic leukemia and solid-organ transplantation. Dermatol Surg 2003; 29: 129-134. (Pubitemid 36188418)
21. Muhleisen B, Petrov I, Gachter T, Kurrer M, Scharer L, Dummer R, et al. Progression of cutaneous squamous cell carcinoma in immunosuppressed patients is associated with reduced CD123+ and FOXP3+ cells in the perineoplastic inflammatory infiltrate. Histopathology 2009; 55: 67-76.
22. Hoyo E, Kanitakis J, Euvrard S, Thivolet J. Proliferation characteristics of cutaneous squamous cell carcinomas developing in organ graft recipients. Comparison with squamous cell carcinomas of nonimmunocompromised hosts by counting argyrophilic proteins associated with nucleolar organizer regions. Arch Dermatol 1993; 129: 324-327.
23. Haeffner AC, Zepter K, Elmets CA, Wood GS. Analysis of tumor-infiltrating lymphocytes in cutaneous squamous cell carcinoma. Arch Dermatol 1997; 133: 585-590. (Pubitemid 27214967)
24. Hussein MR, Ahmed RA. Analysis of the mononuclear inflammatory cell infiltrate in the non-tumorigenic, pretumorigenic and tumorigenic keratinocytic hyperproliferative lesions of the skin. Cancer Biol Ther 2005; 4: 819-821.
25. Bravo Soto JA, Esteban de la Rosa RJ, Luna del Castillo JD, Cerezo Morales S, Garcia Olivares E, Osuna Ortega A, et al. Effect of mycophenolate mofetil regimen on peripheral blood lymphocyte subsets in kidney transplant recipients. Transplantation Proc 2003; 35: 1355-1359.
26. Lebrec H, Roger R, Blot C, Burleson GR, Bohuon C, Pallardy M. Immunotoxicological investigation using pharmaceutical drugs. In vitro evaluation of immune effects using rodent or human immune cells. Toxicology 1995; 96: 147-156.
27. Claudatus JC, Jr., d'Ovidio R, Lospalluti M, Meneghini CL. Skin tumors and reactive cellular infiltrate: further studies. Acta Derm Venereol 1986; 66: 29-34.
28. Fernandez-Bussy R, Cambazard F, Mauduit G, Schmitt D, Thivolet J. T cell subsets and Langerhans cells in skin tumours. Eur J Cancer Clin Oncol 1983; 19: 907-913. (Pubitemid 13031240)
29. Gatter KC, Morris HB, Roach B, Mortimer P, Fleming KA, Mason DY. Langerhans' cells and T cells in human skin tumours: an immunohistological study. Histopathology 1984; 8: 229-244. (Pubitemid 14129005)
30. Habets JM, Tank B, van Joost T. Characterization of the mononuclear infiltrate in Bowen's disease (squamous cell carcinoma in situ). Evidence for a T cell-mediated anti-tumour immune response. Virchows Arch A Pathol Anat Histopathol 1989; 415: 125-130.
31. Kohchiyama A, Oka D, Ueki H. Immunohistologic studies of squamous cell carcinoma: possible participation of Leu7+ (natural killer) cells as antitumor effector cells. J Invest Dermatol 1986; 87: 515-518. (Pubitemid 16027127)
32. Lindelöf B, Dal H, Wolk K, Malmborg N. Cutaneous squamous cell carcinoma in organ transplant recipients: a study of the Swedish cohort with regard to tumor site. Arch Dermatol 2005; 141: 447-451. (Pubitemid 40547403)